Forgiveness of non-adherence to HIV-1 antiretroviral therapy.

PubWeight™: 1.70‹?› | Rank: Top 3%

🔗 View Article (PMID 18256112)

Published in J Antimicrob Chemother on February 06, 2008

Authors

Jonathan Shuter1

Author Affiliations

1: Division of Infectious Diseases and AIDS Center, Montefiore Medical Center/Albert Einstein College of Medicine, 111 E 210th Street, Bronx, NY 10467, USA. jshuter@montefiore.org

Articles citing this

Strategies for promoting adherence to antiretroviral therapy: a review of the literature. Curr Infect Dis Rep (2008) 2.30

Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care STDS (2011) 2.11

The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy. PLoS One (2009) 1.72

Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS. AIDS Patient Care STDS (2009) 1.56

Association between health literacy and HIV treatment adherence: further evidence from objectively measured medication adherence. J Int Assoc Physicians AIDS Care (Chic) (2008) 1.52

Cell-associated HIV RNA: a dynamic biomarker of viral persistence. Retrovirology (2013) 1.37

Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study. BMC Public Health (2011) 1.30

In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450. Antimicrob Agents Chemother (2014) 1.20

Improving coping skills for self-management of treatment side effects can reduce antiretroviral medication nonadherence among people living with HIV. Ann Behav Med (2011) 1.10

Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS Patient Care STDS (2012) 0.99

An analysis of electronically monitored adherence to antiretroviral medications. AIDS Behav (2008) 0.98

Factors associated with nonadherence to antiretroviral therapy in HIV-positive smokers. AIDS Patient Care STDS (2012) 0.95

Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study. PLoS One (2013) 0.95

Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era. Patient Prefer Adherence (2012) 0.93

Development and validation of a measure for intention to adhere to HIV treatment. AIDS Patient Care STDS (2012) 0.83

Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level. HIV AIDS (Auckl) (2011) 0.82

Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines. Clinicoecon Outcomes Res (2013) 0.81

Compliance assessment of ambulatory Alzheimer patients to aid therapeutic decisions by healthcare professionals. BMC Health Serv Res (2010) 0.80

More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1. Elife (2016) 0.79

Retained in HIV Care But Not on Antiretroviral Treatment: A Qualitative Patient-Provider Dyadic Study. PLoS Med (2015) 0.79

Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia. AIDS Res Ther (2014) 0.78

High Current CD4+ T Cell Count Predicts Suboptimal Adherence to Antiretroviral Therapy. PLoS One (2015) 0.76

Conserved T cell and natural killer cell function in treatment-experienced adults receiving tenofovir plus didanosine as nucleoside reverse transcription inhibitor backbone. Clin Exp Immunol (2009) 0.76

"It Makes You Feel Like Someone Cares" acceptability of a financial incentive intervention for HIV viral suppression in the HPTN 065 (TLC-Plus) study. PLoS One (2017) 0.75

Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients. BMC Infect Dis (2017) 0.75

Challenges in initiating antiretroviral therapy in 2010. Can J Infect Dis Med Microbiol (2010) 0.75

Depression at Treatment Initiation Predicts HIV Antiretroviral Adherence in Uganda. J Int Assoc Provid AIDS Care (2016) 0.75

Risk Factors for Non-Adherence to cART in Immigrants with HIV Living in the Netherlands: Results from the ROtterdam ADherence (ROAD) Project. PLoS One (2016) 0.75

Trends in ART Prescription and Viral Suppression Among HIV-Positive Young Adults in Care in the United States, 2009-2013. J Acquir Immune Defic Syndr (2017) 0.75

Pharmacokinetics-based adherence measures for antiretroviral therapy in HIV-infected Kenyan children. J Int AIDS Soc (2017) 0.75